Recombinant antibody technology

Written by Sino Biological
Cancer research Drug discovery and development Immunology

Recombinant antibody technology has addressed many problems associated with hybridoma-based platforms, opening the door to a new class of biologics. Today, this technology continues to contribute to the discovery and development of new antibody-based therapeutics and improve the performance of other biological modalities.

In this article, Sino Biological explores the advantages of recombinant antibody engineering, recombinant antibodies’ distinct requirements for specific applications and their significant potential in future therapeutic development.

Recombinant antibody technology - to BioTechniques

This content was provided by

Follow Sino Biological on LinkedIn and YouTube.